13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q3 2017. See the latest, Q2 2026 →
Reported value
$83.48B
+11% on the quarter before
Positions
241
17 new · 22 sold out
Top 10
20.2%
of the value
Est. gain
+$2.86B
on stocks held all quarter
Est. return
+4.2%
on those stocks since Q2 2017
Positions as of Sep 30, 2017, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 40% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.
Largest buys
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Bank Of New York Mellon Corp~$668.4MAdded · 0.7% → 1.5%+12,607,183 shares
- Vale Sa On ADR~$657.9MNew · 0.0% → 0.8%+65,337,149 shares
- Unitedhealth Group Inc~$647.3MAdded · 0.2% → 1.0%+3,304,902 shares
- Dowdupont Inc~$611.4MNew · 0.0% → 0.7%+8,831,284 shares
- Equifax Inc~$513.9MNew · 0.0% → 0.6%+4,848,946 shares
- Lockheed Martin Corp~$446.5MAdded · 1.2% → 1.7%+1,439,006 shares
- Gilead Sciences Inc~$421.8MAdded · 0.6% → 1.1%+5,205,983 shares
- Abbvie Inc~$404.4MAdded · 0.3% → 0.8%+4,550,954 shares
- Intel~$339.6MNew · 0.0% → 0.4%+8,917,108 shares
- Qualcomm~$327.8MAdded · 1.1% → 1.3%+6,322,645 shares
Largest sells
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vale Sa Pna ADR~$568.4MSold out · 0.8% → 0.0%−69,738,541 shares
- Dow Chemical Co~$441.9MSold out · 0.6% → 0.0%−7,006,529 shares
- Automatic Data Processing~$403.0MSold out · 0.5% → 0.0%−3,933,700 shares
- Waste Management Inc~$333.7MCut · 0.7% → 0.3%−4,264,001 shares
- General Electric Co~$332.5MCut · 0.8% → 0.2%−13,752,316 shares
- AT&T~$280.3MCut · 0.7% → 0.3%−7,156,200 shares
- Canadian National Railway Co (Usd)~$238.4MSold out · 0.3% → 0.0%−2,941,329 shares
- Astrazeneca Plc ADR~$223.5MCut · 0.8% → 0.4%−6,597,100 shares
- Medtronic Plc~$223.2MCut · 0.9% → 0.4%−2,869,482 shares
- Pfizer Inc~$206.4MCut · 1.7% → 1.4%−5,780,200 shares
Holdings
As of Sep 30, 2017. Changes are in shares against Jun 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON STOCK · shares −1.0% · price +8.1% | 2.8% | $2.38B | +$177.6M | ||||||||
| Verizon Communications IncCOMMON STOCK · shares −9.5% · price +10.8% | 2.2% | $1.82B | +$177.7M | ||||||||
| Jpmorgan Chase And CoCOMMON STOCK · shares +4.6% · price +4.5% | 2.1% | $1.73B | +$71.0M | ||||||||
| Enbridge IncCOMMON STOCK · shares +7.8% · price +5.0% | 2.1% | $1.72B | +$75.8M | ||||||||
| Coca-Cola CoCOMMON STOCK · shares −0.6% · price +0.4% | 2.0% | $1.70B | +$6.0M | ||||||||
| Cme Group Inc Cl ACOMMON STOCK · shares +11% · price +8.3% | 2.0% | $1.69B | +$117.0M | ||||||||
| Chevron CorpCOMMON STOCK · shares −1.5% · price +12.6% | 2.0% | $1.67B | +$187.7M | ||||||||
| Lockheed Martin CorpCOMMON STOCK · shares +45% · price +11.8% | 1.7% | $1.44B | +$104.9M | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares +0.1% · price −5.5% | 1.7% | $1.40B | −$81.4M | ||||||||
| Texas InstrumentsCOMMON STOCK · shares +3.0% · price +16.5% | 1.6% | $1.33B | +$182.5M | ||||||||
| Comcast Corp Cl ACOMMON STOCK · shares +23% · price −1.1% | 1.6% | $1.32B | −$12.2M | ||||||||
| Sempra EnergyCOMMON STOCK · shares +15% · price +1.2% | 1.6% | $1.31B | +$13.8M | ||||||||
| Chubb LtdCOMMON STOCK · shares +16% · price −1.9% | 1.5% | $1.28B | −$21.9M | ||||||||
| Boeing CoCOMMON STOCK · shares −3.7% · price +28.6% | 1.5% | $1.27B | +$282.8M | ||||||||
| Visa Inc.COMMON STOCK · shares +6.9% · price +12.2% | 1.5% | $1.25B | +$127.6M | ||||||||
| Bank Of New York Mellon CorpCOMMON STOCK · shares +121% · price +3.9% | 1.5% | $1.22B | +$20.9M | ||||||||
| Starbucks CorpCOMMON STOCK · shares +28% · price −7.9% | 1.4% | $1.14B | −$76.2M | ||||||||
| Pfizer IncCOMMON STOCK · shares −15% · price +6.3% | 1.4% | $1.14B | +$67.5M | ||||||||
| Monsanto CoCOMMON STOCK · shares +10% · price +1.2% | 1.3% | $1.12B | +$12.4M | ||||||||
| Wells Fargo And CoCOMMON STOCK · shares +6.2% · price −0.5% | 1.3% | $1.11B | −$4.9M | ||||||||
| QualcommCOMMON STOCK · shares +42% · price −6.1% | 1.3% | $1.11B | −$51.1M | ||||||||
| Deere And CoCOMMON STOCK · shares +35% · price +1.6% | 1.3% | $1.11B | +$13.0M | ||||||||
| Marsh And Mclennan Companies IncCOMMON STOCK · shares +11% · price +7.5% | 1.3% | $1.05B | +$66.0M | ||||||||
| Pgande CorpCOMMON STOCK · shares +8.4% · price +2.6% | 1.1% | $929.9M | +$21.7M | ||||||||
| Gilead Sciences IncCOMMON STOCK · shares +87% · price +14.5% | 1.1% | $908.8M | +$61.6M | ||||||||
| Total · 241 positions | 100% | $83.48B | +$2.86B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2017 to Q3 2017: 216 stocks held throughout, up $2.86B (+4.2%).
- Boeing Co+$282.8M+29%
- Chevron Corp+$187.7M+13%
- Texas Instruments+$182.5M+17%
- Verizon Communications Inc+$177.7M+11%
- Microsoft+$177.6M+8%
- Incyte Corp−$58.8M−7%
- Nike Inc Cl B−$60.0M−12%
- Starbucks Corp−$76.2M−8%
- Philip Morris International−$81.4M−5%
- Newell Brands Inc−$158.1M−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |